These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 7595374

  • 1. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A, Nerstedt A, Jansson A, Rymo L.
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [Abstract] [Full Text] [Related]

  • 2. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
    Sjöblom A, Jansson A, Yang W, Laín S, Nilsson T, Rymo L.
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman SR.
    J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion.
    Kempkes B, Pawlita M, Zimber-Strobl U, Eissner G, Laux G, Bornkamm GW.
    Virology; 1995 Dec 20; 214(2):675-9. PubMed ID: 8553575
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM, Smith SM, D'Souza BN, Loughran ST, Maier S, Kempkes B, Cahill PA, Simmons MJ, Gélinas C, Walls D.
    J Virol; 2006 Aug 20; 80(16):8133-44. PubMed ID: 16873269
    [Abstract] [Full Text] [Related]

  • 9. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
    Groves AK, Cotter MA, Subramanian C, Robertson ES.
    J Virol; 2001 Oct 20; 75(19):9446-57. PubMed ID: 11533207
    [Abstract] [Full Text] [Related]

  • 10. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
    Laux G, Adam B, Strobl LJ, Moreau-Gachelin F.
    EMBO J; 1994 Dec 01; 13(23):5624-32. PubMed ID: 7988559
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
    Waltzer L, Perricaudet M, Sergeant A, Manet E.
    J Virol; 1996 Sep 01; 70(9):5909-15. PubMed ID: 8709211
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.
    Fuentes-Pananá EM, Ling PD.
    J Virol; 1998 Jan 01; 72(1):693-700. PubMed ID: 9420275
    [Abstract] [Full Text] [Related]

  • 18. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV.
    Yalamanchili R, Tong X, Grossman S, Johannsen E, Mosialos G, Kieff E.
    Virology; 1994 Nov 01; 204(2):634-41. PubMed ID: 7941331
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S.
    J Virol; 1993 May 01; 67(5):2853-61. PubMed ID: 8386279
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
    Marshall D, Sample C.
    J Virol; 1995 Jun 01; 69(6):3624-30. PubMed ID: 7745710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.